Formoterol Monotherapy Compared with Combined Ipratropium Bromide plus Fenoterol in the Treatment of Chronic Obstructive Pulmonary Disease

Author： Konermann M.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.21, Iss.4, 2001-04, pp. : 235-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of Ipratropium Bromide/Fenoterol Hydrobromide (Berodual ® ) Delivered Via Respimat ® Soft Mist™ Inhaler in Patients with Asthma and Chronic Obstructive Pulmonary Disease

By Frank Kässner  

Drugs, Vol. 64, Iss. 15, 2004-01 ,pp. : 1671-1682

Adis International

Access to resources Recommend Favorite

Inhaled albuterol/salbutamol and ipratropium bromide and their combination in the treatment of chronic obstructive pulmonary disease

By Gordon Joshiah   Panos Ralph J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 6, Iss. 3, 2010-03 ,pp. : 381-392

Informa Healthcare

Access to resources Recommend Favorite

Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario   Rogliani Paola   Matera Maria Gabriella  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 6, 2013-04 ,pp. : 775-781

Informa Healthcare

Access to resources Recommend Favorite

Formoterol plus tiotropium bromide is more effective than either drug alone in patients with acute exacerbation of chronic obstructive pulmonary disease

By  

Inpharma, Vol. 1, Iss. 1566, 2006-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Aclidinium bromide for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario   Page Clive P   Matera Maria Gabriella  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1205-1214

Informa Healthcare

Access to resources Recommend Favorite